https://prostatecanceruk.org/research/research-impact/targeting-resistant-prostate-cancer-with-precision-radiotherapy
A trial supported by Prostate Cancer UK found that Stereotactic Body Radiotherapy (SBRT) is a safe, effective treatment for oligoprogressive advanced prostate...
prostate cancertargetingresistantprecisionradiotherapy
https://www.pharmaceutical-technology.com/data-insights/ibrance-pfizer-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-348885&utm_campaign=recommended-articles-pi
Ibrance is under clinical development by Pfizer and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
prostate canceribrancepfizermetastaticcastration
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-nktr-102-for-advanced-ovarian-cancer-that-is-resistant-to-platinum-drugs
This trial looked at a drug called etirinotecan pegol (also known as NKTR-102) for women with ovarian cancer.
etirinotecan pegolovarian cancertrialadvanced
https://www.pharmaceutical-technology.com/data-insights/nuv-1511-nuvation-bio-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/
NUV-1511 is under clinical development by Nuvation Bio and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
nuvbiometastaticcastrationresistant
https://www.pharmaceutical-technology.com/data-insights/inkmune-inmune-bio-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/
INKmune is under clinical development by Inmune Bio and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
prostate cancerbiometastaticcastrationresistant
https://www.marketresearchfuture.com/reports/pd-1-resistant-head-neck-cancer-market-37163
PD-1 Resistant Head and Neck Cancer Market growth is projected to reach USD 4.90 Billion, at a 12.02% CAGR by driving industry size, share, top company...
neck cancermarket reportpdresistanthead
https://www.mdpi.com/2077-0383/12/22/7130
Background: prostate-specific membrane antigen (PSMA) ligand PET has been recently incorporated into international guidelines for several different indications...
psma petprostate cancerctcastrationresistant
https://www.pharmaceutical-technology.com/data-insights/mhb-088c-minghui-pharmaceutical-shanghai-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/
MHB-088C is under clinical development by Minghui Pharmaceutical (Shanghai) and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer...
mhbpharmaceuticalshanghaimetastaticcastration
https://www.dkfz.de/en/news/press-releases/detail/malignant-network-makes-brain-cancer-resistant
Glioblastoma is the most malignant type of brain cancer. Physicians and scientists from the German Cancer Research Center (DKFZ) and from Heidelberg University...
brain cancergerman researchmalignantnetworkmakes
https://www.expertmarketresearch.com/request?type=report&flag=C&id=17152
The major companies developing drugs for castrate resistant prostate cancer include Evopoint Biosciences Inc. and FibroGen, among others.
prostate cancercastrateresistantpipelineinsight
https://www.pharmaceutical-technology.com/news/newsradium-223-chloride-shows-efficacy-against-crpc-bayer-study/
Bayer HealthCare Pharmaceuticals' investigational radium-223 chloride has met the primary and secondary endpoints of a Phase III prostate cancer trial.
prostate cancerradiumchlorideshowsefficacy
https://www.pharmaceutical-technology.com/data-insights/botensilimab-agenus-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/
Botensilimab is under clinical development by Agenus and currently in Phase I for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
prostate canceragenusmetastaticcastrationresistant
https://www.nextbigfuture.com/2006/07/other-tech-white-blood-cells-from.html
White blood cells from a strain of cancer-resistant mice cured advanced cancers in ordinary laboratory mice, researchers at Wake Forest University School of
white blood cellstechcancerresistantmice
https://www.sciencedaily.com/releases/2018/10/181022122901.htm
Researchers have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which...
new drugblood cancercombinationdestroyschemo
https://www.pharmaceutical-technology.com/data-insights/avelumab-merck-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/
Avelumab is under clinical development by Merck and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
prostate canceravelumabmerckmetastaticcastration
https://pubmed.ncbi.nlm.nih.gov/17086220/
Hormone-resistant prostate cancer is defined by disease progression despite of castration levels of serum testosterone. Due to a good palliative effect and low...
prostate cancertreatmenthormoneresistant
https://www.news-medical.net/news/20250404/ChemoID-test-leads-to-better-outcomes-in-platinum-resistant-ovarian-cancer.aspx
Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can accurately choose more effective...
test leadsbetter outcomesplatinumresistantovarian
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1231460/full
Metabolic reprogramming is a phenomenon in which cancer cells alter their metabolic pathways to support their uncontrolled growth and survival. Platinum-base...
frontiersmetabolicreprogrammingthreemajor
https://www.massgeneral.org/news/press-release/what-makes-brain-tumor-cells-resistant-to-treatment
A team led by investigators at Massachusetts General Hospital (MGH) has now uncovered a mechanism used by glioblastoma cells to become aggressive and resistant...
brain cancerstudyrevealsmakescells
https://www.sciencedaily.com/releases/2014/04/140408154107.htm
A novel compound, COH-SR4, can target and treat drug-resistant lung cancers, research suggests. The researchers conclude: "the results from our in-vitro and...
drug resistantlung cancernovelcompoundsciencedaily
https://theweek.com/antibiotics/51908/antibiotics-resistance-could-cause-10m-deaths-a-year-by-2050
Drug-resistant infections could kill 50 million people worldwide by 2050
antibiotic resistantsuperbugskillcancer
https://pubmed.ncbi.nlm.nih.gov/24287876/
Pao extract, derived from bark of Amazonian tree Pao Pereira, is commonly used in South American medicine. A recent study showed that Pao extract repressed...
prostate cancercell growthpaopereiraextract
https://pubmed.ncbi.nlm.nih.gov/19800775/
Berberine is a pure phenanthren alkaloid isolated from the roots and bark of herbal plants such as Berberis, Hydrastis canadensis and Coptis chinensis....
alkaloidberberinegrowthanoikisresistant
https://pubmed.ncbi.nlm.nih.gov/35717046/
Prostate cancer is a significant cause of morbidity and mortality among men worldwide. Although most patients present with localized or regional disease and...
prostate cancerradiummetastaticcastrateresistant
https://www.pharmaceutical-technology.com/data-insights/db-1310-duality-biologics-shanghai-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/
DB-1310 is under clinical development by Duality Biologics (Shanghai) and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
dbdualitybiologicsshanghaimetastatic
https://www.technologynetworks.com/cancer-research/news/dietary-supplement-may-help-combat-drug-resistant-breast-cancer-372002
A dietary supplement has been found to restore the sensitivity of cancer cells to an advanced breast cancer drug, alpelisib.
dietary supplementdrug resistantbreast cancermayhelp
https://www.woolworths.com.au/shop/productdetails/699445/cancer-council-day-wear-water-resistant-spf-50-
Check out cancer council day wear water resistant spf 50+ 75ml at woolworths.com.au. Order 24/7 at our online supermarket
cancer councilday wearwater resistantspfwoolworths
https://pubmed.ncbi.nlm.nih.gov/29167821/
The non-receptor tyrosine kinase, PTK6/BRK, is highly expressed in multiple tumor types, including prostate, ovarian, and breast cancers, and regulates...
endocrine therapygrowthsurvivalresistant
https://www.sciencedaily.com/releases/2013/04/130403071435.htm
Poly (ADP-ribose) polymerase inhibitors may be a novel treatment strategy for patients with cancer that has become resistant to the commonly used chemotherapy...
resistant canceranticancer drugscisplatincellssensitive
https://www.broadinstitute.org/news/cracks-armor-therapy-resistant-cancer-cells
Broad Institute is a multidisciplinary community of researchers on a mission to improve human health.
resistant cancercracksarmortherapycells
https://www.sciencedaily.com/releases/2012/05/120509111440.htm
Researchers have developed a miniaturized biochip for investigating the effect of drugs on cancer stem cells. This new technology could boost the development...
cancer stem cellsdrug resistantdropletarraysheds
https://www.clinicaltrialsarena.com/analyst-comment/esmo25-relacorilant-shows-sustained-efficacy-in-parp-exposed-resistant-ovarian-cancer/
Most recurrent ovarian cancer cases arise in patients previously treated with PARP inhibitors making these relacorilant results noteworthy.
esmorelacorilantshowssustainedefficacy
https://www.expertmarketresearch.com/clinical-trials/castrate-resistant-prostate-cancer-pipeline-insight/pricing-detail
The major companies developing drugs for castrate resistant prostate cancer include Evopoint Biosciences Inc. and FibroGen, among others.
prostate cancercastrateresistantpipelineinsight
https://sciencedaily.com/releases/2025/02/250204132413.htm
Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models...
brain cancer researchbreakthroughchildhoodcouldheal